Epilepsy Research
Volume 27, Issue 3 , Pages 205-213 , June 1997

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy1

  • Marilisa M Guerreiro

      Affiliations

    • Neurological Department, Faculty of Medicine, UNICAMP, Campinas, Brazil
    • ,
  • Ulf Vigonius

      Affiliations

    • Novartis Sverige AB, Västra Frölunda, Sweden
    • Corresponding Author InformationCorresponding author. Present address: Novartis Sverige AB, P.O. Box 1150, S-183 11 Taeby, Sweden.
    • ,
  • Harald Pohlmann

      Affiliations

    • Novartis Pharma AG, Basel, Switzerland
    • ,
  • Maria Luiza G de Manreza

      Affiliations

    • Neurological Department, Hospital Das Clinicas, Sao Paulo, Brazil
    • ,
  • Natalio Fejerman

      Affiliations

    • Neurological Department, Children Hospital `Professor Dr Juan P. Garrahan', Buenos Aires, Argentina
    • ,
  • Sergio A Antoniuk

      Affiliations

    • Neurological Department, Hospital Nossa Senhora das Gracas, Curitiba, Brazil
    • ,
  • Alan Moore

      Affiliations

    • Novartis Pharma AG, Basel, Switzerland

Received 26 March 1997 ,Revised 11 April 1997 ,Accepted 13 April 1997.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-1211(97)00025-9

Epilepsy Research
Volume 27, Issue 3 , Pages 205-213 , June 1997

Article Tools

* Image Usage & Resolution